Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

ABSTRACT: The purpose of this study is to evaluate the efficacy of S 95005 in patients with metastatic colorectal cancer (mCRC) who are refractory or intolerant to standard chemotherapies in terms of Progression-Free Survival rate at 2 months in the Russian population.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms,Cancer

PROVIDER: 2253724 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR